Advances in understanding pituitary adenomas.

Hormone research Pub Date : 2009-04-01 Epub Date: 2009-04-29 DOI:10.1159/000192441
Vera Popović-Brkić
{"title":"Advances in understanding pituitary adenomas.","authors":"Vera Popović-Brkić","doi":"10.1159/000192441","DOIUrl":null,"url":null,"abstract":"signalling pathways have been identified as important factors in the development of pituitary tumours, our understanding of pituitary tumorigenesis remains incomplete and is the focus of current research. This is because current treatment modalities fail to completely control this disorder and prevent the associated morbidity and mortality. Pituitary microadenomas, which have a diameter of less than 1 cm, are exceedingly common at autopsy and on pituitary imaging, with a prevalence of 25%. Most microadenomas remain clinically occult and stable in size without an increase in tumour cells and without local mass effects. Recent studies try to explain this cessation of growth in a neoplasm, which would not be expected to occur. It was thought that apoptosis may play a role in curtailing outgrowth, but this did not explain the maintenance of a stable size for years. Lack of induction of vascular stroma was thought to be relevant, but again was an insufficient explanation. Proliferative activity of microadenomas is very low, indicating that the tumour cells are growth arrested, and in his presentation at the 10th KIGS/ KIMS Expert Meeting, Wolter Mooi introduced the currently most likely factor for growth arrest. The hypothesis is that cells after a certain number of cell divisions display a change in cell phenotype (i.e. they enter into a senescence-like state). Thus, growth arrest in pituitary microadenomas may be due to oncogene-induced cellular senescence. The demonstration that the majority of","PeriodicalId":13225,"journal":{"name":"Hormone research","volume":"71 Suppl 2 ","pages":"75-7"},"PeriodicalIF":0.0000,"publicationDate":"2009-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000192441","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hormone research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000192441","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2009/4/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

signalling pathways have been identified as important factors in the development of pituitary tumours, our understanding of pituitary tumorigenesis remains incomplete and is the focus of current research. This is because current treatment modalities fail to completely control this disorder and prevent the associated morbidity and mortality. Pituitary microadenomas, which have a diameter of less than 1 cm, are exceedingly common at autopsy and on pituitary imaging, with a prevalence of 25%. Most microadenomas remain clinically occult and stable in size without an increase in tumour cells and without local mass effects. Recent studies try to explain this cessation of growth in a neoplasm, which would not be expected to occur. It was thought that apoptosis may play a role in curtailing outgrowth, but this did not explain the maintenance of a stable size for years. Lack of induction of vascular stroma was thought to be relevant, but again was an insufficient explanation. Proliferative activity of microadenomas is very low, indicating that the tumour cells are growth arrested, and in his presentation at the 10th KIGS/ KIMS Expert Meeting, Wolter Mooi introduced the currently most likely factor for growth arrest. The hypothesis is that cells after a certain number of cell divisions display a change in cell phenotype (i.e. they enter into a senescence-like state). Thus, growth arrest in pituitary microadenomas may be due to oncogene-induced cellular senescence. The demonstration that the majority of
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
垂体腺瘤的认识进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hormone research
Hormone research 医学-内分泌学与代谢
自引率
0.00%
发文量
0
期刊最新文献
Growth hormone therapy in Noonan syndrome: growth response and characteristics. GH therapy in Noonan syndrome: Review of final height data. Growth hormone and the heart in Noonan syndrome. Response to growth hormone in short children with Noonan syndrome: correlation to genotype. Genetic and pathogenetic aspects of Noonan syndrome and related disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1